77 related articles for article (PubMed ID: 20966551)
1. Hyperphosphorylated truncated protein tau induces caspase-3 independent apoptosis-like pathway in the Alzheimer's disease cellular model.
Zilkova M; Zilka N; Kovac A; Kovacech B; Skrabana R; Skrabanova M; Novak M
J Alzheimers Dis; 2011; 23(1):161-9. PubMed ID: 20966551
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells rescue the Alzheimer's disease cell model from cell death induced by misfolded truncated tau.
Zilka N; Zilkova M; Kazmerova Z; Sarissky M; Cigankova V; Novak M
Neuroscience; 2011 Oct; 193():330-7. PubMed ID: 21763758
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of tau proteins antagonizes amyloid-beta-potentiated apoptosis through mitochondria-caspase-3 pathway in N2a cells.
Wang ZF; Yin J; Zhang Y; Zhu LQ; Tian Q; Wang XC; Li HL; Wang JZ
J Alzheimers Dis; 2010; 20(1):145-57. PubMed ID: 20164595
[TBL] [Abstract][Full Text] [Related]
4. Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors.
Wang HH; Li HL; Liu R; Zhang Y; Liao K; Wang Q; Wang JZ; Liu SJ
J Alzheimers Dis; 2010; 21(1):167-79. PubMed ID: 20413892
[TBL] [Abstract][Full Text] [Related]
5. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
6. Pathological effects of glyoxalase I inhibition in SH-SY5Y neuroblastoma cells.
Kuhla B; Lüth HJ; Haferburg D; Weick M; Reichenbach A; Arendt T; Münch G
J Neurosci Res; 2006 Jun; 83(8):1591-600. PubMed ID: 16555297
[TBL] [Abstract][Full Text] [Related]
7. Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment.
Garg S; Timm T; Mandelkow EM; Mandelkow E; Wang Y
Neurobiol Aging; 2011 Jan; 32(1):1-14. PubMed ID: 20961659
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of tau leads to the stimulation of neurite outgrowth, the activation of caspase 3 activity, and accumulation and phosphorylation of tau in neuroblastoma cells on cAMP treatment.
Yoshizaki C; Tsukane M; Yamauchi T
Neurosci Res; 2004 Aug; 49(4):363-71. PubMed ID: 15236861
[TBL] [Abstract][Full Text] [Related]
9. Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
Zilka N; Filipcik P; Koson P; Fialova L; Skrabana R; Zilkova M; Rolkova G; Kontsekova E; Novak M
FEBS Lett; 2006 Jun; 580(15):3582-8. PubMed ID: 16753151
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
11. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
[TBL] [Abstract][Full Text] [Related]
12. Activation of caspase-8 in the Alzheimer's disease brain.
Rohn TT; Head E; Nesse WH; Cotman CW; Cribbs DH
Neurobiol Dis; 2001 Dec; 8(6):1006-16. PubMed ID: 11741396
[TBL] [Abstract][Full Text] [Related]
13. Induction of Bcl-2 and Bax was related to hyperphosphorylation of tau and neuronal death induced by okadaic acid in rat brain.
Chen LQ; Wei JS; Lei ZN; Zhang LM; Liu Y; Sun FY
Anat Rec A Discov Mol Cell Evol Biol; 2005 Dec; 287(2):1236-45. PubMed ID: 16265626
[TBL] [Abstract][Full Text] [Related]
14. Proapoptotic effects of tau cleavage product generated by caspase-3.
Chung CW; Song YH; Kim IK; Yoon WJ; Ryu BR; Jo DG; Woo HN; Kwon YK; Kim HH; Gwag BJ; Mook-Jung IH; Jung YK
Neurobiol Dis; 2001 Feb; 8(1):162-72. PubMed ID: 11162250
[TBL] [Abstract][Full Text] [Related]
15. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in oligodendrocytes is associated with axonal degeneration in P301L tau mice.
Zehr C; Lewis J; McGowan E; Crook J; Lin WL; Godwin K; Knight J; Dickson DW; Hutton M
Neurobiol Dis; 2004 Apr; 15(3):553-62. PubMed ID: 15056463
[TBL] [Abstract][Full Text] [Related]
17. NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation.
Amadoro G; Ciotti MT; Costanzi M; Cestari V; Calissano P; Canu N
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2892-7. PubMed ID: 16477009
[TBL] [Abstract][Full Text] [Related]
18. Different tau epitopes define Abeta42-mediated tau insolubility.
Pennanen L; Götz J
Biochem Biophys Res Commun; 2005 Dec; 337(4):1097-101. PubMed ID: 16226718
[TBL] [Abstract][Full Text] [Related]
19. Co-localization of hyperphosphorylated tau and caspases in the brainstem of Alzheimer's disease patients.
Wai MS; Liang Y; Shi C; Cho EY; Kung HF; Yew DT
Biogerontology; 2009 Aug; 10(4):457-69. PubMed ID: 18946722
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
